Kazunori Ohnishi
Oncology Center
Hamamatsu University School of Medicine
Hamamatsu
Japan
Name/email consistency: high
- Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study. Ohnishi, K., Nakaseko, C., Takeuchi, J., Fujisawa, S., Nagai, T., Yamazaki, H., Tauchi, T., Imai, K., Mori, N., Yagasaki, F., Maeda, Y., Usui, N., Miyazaki, Y., Miyamura, K., Kiyoi, H., Ohtake, S., Naoe, T. Cancer Sci. (2012)
- PML-RARalpha inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemia. Ohnishi, K. Int. J. Clin. Oncol. (2007)
- Multicenter prospective study of interferon alpha versus allogeneic stem cell transplantation for patients with new diagnoses of chronic myelogenous leukemia. Ohnishi, K., Ino, A., Kishimoto, Y., Usui, N., Shimazaki, C., Ohtake, S., Taguchi, H., Yagasaki, F., Tomonaga, M., Hotta, T., Ohno, R. Int. J. Hematol. (2004)
- Multicenter prospective study of interferon-alpha versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia: a preliminary analysis. Ohnishi, K., Ino, T., Kishimoto, Y., Usui, N., Shimazaki, C., Ohtake, S., Taguchi, H., Kusumoto, S., Kuriyama, K., Hotta, T., Ohno, R. Cancer Chemother. Pharmacol. (2001)
- Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group. Ohnishi, K., Minami, S., Ueda, T., Nishimura, M., Tsubaki, K., Takemoto, Y., Takeshita, A., Sao, H., Kageyama, S., Ueda, R., Ohno, R. Int. J. Hematol. (2000)
- Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ohnishi, K., Yoshida, H., Shigeno, K., Nakamura, S., Fujisawa, S., Naito, K., Shinjo, K., Fujita, Y., Matsui, H., Takeshita, A., Sugiyama, S., Satoh, H., Terada, H., Ohno, R. Ann. Intern. Med. (2000)